| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
|
N Engl J Med
|
2003
|
8.48
|
|
2
|
Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.
|
Med Pediatr Oncol
|
2002
|
8.03
|
|
3
|
The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research.
|
J Clin Oncol
|
2009
|
5.86
|
|
4
|
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.
|
BMJ
|
2009
|
5.53
|
|
5
|
New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
|
J Natl Cancer Inst
|
2006
|
3.90
|
|
6
|
Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.
|
J Natl Cancer Inst
|
2009
|
3.52
|
|
7
|
Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study.
|
J Clin Oncol
|
2008
|
3.27
|
|
8
|
Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
|
J Natl Cancer Inst
|
2010
|
3.23
|
|
9
|
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.
|
J Clin Oncol
|
2003
|
3.15
|
|
10
|
Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
|
J Clin Oncol
|
2009
|
2.93
|
|
11
|
Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study.
|
J Clin Oncol
|
2005
|
2.76
|
|
12
|
Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
|
J Clin Oncol
|
2009
|
2.54
|
|
13
|
Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study.
|
J Clin Oncol
|
2003
|
2.50
|
|
14
|
Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
|
Am J Obstet Gynecol
|
2002
|
2.48
|
|
15
|
Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study.
|
J Clin Oncol
|
2009
|
2.47
|
|
16
|
Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study.
|
Neuropsychology
|
2009
|
2.29
|
|
17
|
Female survivors of childhood cancer: preterm birth and low birth weight among their children.
|
J Natl Cancer Inst
|
2006
|
2.28
|
|
18
|
Profile of daily life in children with brain tumors: an assessment of health-related quality of life.
|
J Clin Oncol
|
2005
|
2.26
|
|
19
|
Genetic effects of radiotherapy for childhood cancer: gonadal dose reconstruction.
|
Int J Radiat Oncol Biol Phys
|
2004
|
2.13
|
|
20
|
Radiation dose and breast cancer risk in the childhood cancer survivor study.
|
J Clin Oncol
|
2009
|
1.87
|
|
21
|
Genetic effects of radiotherapy for childhood cancer.
|
Health Phys
|
2003
|
1.84
|
|
22
|
Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study.
|
Radiat Res
|
2010
|
1.68
|
|
23
|
High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance.
|
J Clin Oncol
|
2009
|
1.68
|
|
24
|
Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
|
J Clin Oncol
|
2007
|
1.67
|
|
25
|
Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers.
|
Radiat Res
|
2006
|
1.58
|
|
26
|
Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
|
J Clin Oncol
|
2009
|
1.57
|
|
27
|
Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984-1997: a report from the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2010
|
1.55
|
|
28
|
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.
|
JAMA
|
2012
|
1.48
|
|
29
|
Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.46
|
|
30
|
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2007
|
1.43
|
|
31
|
Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.42
|
|
32
|
Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
|
J Clin Oncol
|
2004
|
1.39
|
|
33
|
Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
|
J Clin Oncol
|
2010
|
1.39
|
|
34
|
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
|
J Clin Oncol
|
2004
|
1.37
|
|
35
|
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
|
J Clin Oncol
|
2006
|
1.31
|
|
36
|
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.
|
Pediatr Blood Cancer
|
2013
|
1.27
|
|
37
|
Rhabdomyosarcoma: many similarities, a few philosophical differences.
|
J Clin Oncol
|
2005
|
1.23
|
|
38
|
Pregnancy outcome of partners of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
|
J Clin Oncol
|
2003
|
1.23
|
|
39
|
Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
|
Blood
|
2008
|
1.21
|
|
40
|
Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.19
|
|
41
|
Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.10
|
|
42
|
Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
|
J Clin Oncol
|
2011
|
1.08
|
|
43
|
Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the childhood cancer survivor study.
|
Pediatr Blood Cancer
|
2005
|
1.06
|
|
44
|
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
|
J Clin Oncol
|
2004
|
1.05
|
|
45
|
Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children's Oncology Group.
|
J Clin Oncol
|
2010
|
1.04
|
|
46
|
Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group.
|
J Clin Oncol
|
2010
|
1.03
|
|
47
|
Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
|
Eur J Cancer
|
2004
|
1.03
|
|
48
|
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
|
Med Pediatr Oncol
|
2002
|
1.03
|
|
49
|
Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.02
|
|
50
|
Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation.
|
J Clin Oncol
|
2002
|
1.01
|
|
51
|
Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group.
|
Cancer
|
2011
|
1.00
|
|
52
|
Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2011
|
0.99
|
|
53
|
High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices.
|
J Clin Oncol
|
2004
|
0.99
|
|
54
|
Radiation therapy for intracranial germ cell tumors.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.98
|
|
55
|
Pulmonary outcomes in survivors of childhood central nervous system malignancies: a report from the Childhood Cancer Survivor Study.
|
Pediatr Blood Cancer
|
2013
|
0.96
|
|
56
|
Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
|
J Clin Oncol
|
2011
|
0.96
|
|
57
|
Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
|
Clin Cancer Res
|
2004
|
0.96
|
|
58
|
Primary radiotherapy for localized orbital MALT lymphoma.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.92
|
|
59
|
Treatment of pediatric hodgkin lymphoma.
|
Curr Treat Options Oncol
|
2008
|
0.92
|
|
60
|
Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.92
|
|
61
|
Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.
|
Pediatr Blood Cancer
|
2004
|
0.91
|
|
62
|
Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group.
|
Cancer
|
2014
|
0.90
|
|
63
|
Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
|
J Clin Oncol
|
2003
|
0.90
|
|
64
|
Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
|
J Clin Oncol
|
2003
|
0.90
|
|
65
|
Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
|
Int J Cancer
|
2014
|
0.88
|
|
66
|
The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.88
|
|
67
|
Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.87
|
|
68
|
Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.
|
J Clin Oncol
|
2012
|
0.85
|
|
69
|
Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study.
|
Fertil Steril
|
2011
|
0.84
|
|
70
|
Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.83
|
|
71
|
Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
|
Pediatr Blood Cancer
|
2007
|
0.81
|
|
72
|
Finding the balance in pediatric Hodgkin's lymphoma.
|
J Clin Oncol
|
2012
|
0.81
|
|
73
|
External beam radiation therapy enhances local control in pigmented villonodular synovitis.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.81
|
|
74
|
Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study.
|
Arch Phys Med Rehabil
|
2013
|
0.80
|
|
75
|
Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2008
|
0.78
|
|
76
|
Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.78
|
|
77
|
Age-related toxicity in patients with rhabdomyosarcoma: a report from the children's oncology group.
|
J Pediatr Hematol Oncol
|
2014
|
0.76
|
|
78
|
Understanding the risk of second malignant tumors in children with Hodgkin's disease.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.75
|
|
79
|
Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.
|
Am J Clin Oncol
|
2016
|
0.75
|
|
80
|
Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy.
|
Pediatr Blood Cancer
|
2013
|
0.75
|
|
81
|
ALARA: in radiation oncology and diagnostic imaging alike.
|
Oncology (Williston Park)
|
2014
|
0.75
|
|
82
|
Resectable pediatric nonrhabdomyosarcoma soft tissue sarcoma: which patients benefit from adjuvant radiation therapy and how much?
|
ISRN Oncol
|
2012
|
0.75
|
|
83
|
Continuing medical education in radiology: a glimpse of the present and of what lies ahead.
|
J Am Coll Radiol
|
2005
|
0.75
|
|
84
|
A tribute to Malcolm A. Bagshaw--an innovative physician who soared to success.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.75
|
|
85
|
Controversies in radiotherapy for pediatric Hodgkin's lymphoma.
|
Expert Rev Anticancer Ther
|
2011
|
0.75
|